A cybersecurity framework for medical devices and health-care technology needs to be developed in a partnership between the government, manufacturers and health-care providers, officials from across the public and private sectors during a workshop convened by the U.S. Food and Drug Administration.
“Right now, for cybersecurity, we’re all in a reactive mode,” said Deborah Kobza, executive director of the National Healthcare Information Sharing and Analysis Center. “We need to change that to be in a preventive mode.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
